Adicet Bio, Inc. Interest Receivable, Current
Adicet Bio, Inc. (ACET) had Interest Receivable, Current of $439.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes
us-gaap:InterestReceivableCurrent · last filed 2026-08-05
- 2026-06-30: Interest Receivable, Current $439.00K.
- 2026-03-31: Interest Receivable, Current $405.00K.
- 2025-12-31: Interest Receivable, Current $342.00K.
- 2025-09-30: Interest Receivable, Current $169.00K.
| Period end | Interest Receivable, Current | Interest Receivable, Current as first filed |
|---|---|---|
| 2026-06-30 | $439.00K 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $405.00K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $342.00K 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $169.00K 10-Q · filed 2025-11-05 | |
| 2024-12-31 | $97.00K 10-K · filed 2026-03-12 | |
| 2024-09-30 | $210.00K 10-Q · filed 2024-11-06 | |
| 2023-12-31 | $0.00 10-Q · filed 2024-11-06 | |
| 2023-09-30 | $20.00K 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $639.00K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $567.00K 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $435.00K 10-K · filed 2024-03-19 | |
| 2022-09-30 | $259.00K 10-Q · filed 2022-11-08 | |
| 2021-12-31 | $29.00K 10-K · filed 2023-03-15 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $1.00K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $22.00K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $23.00K 10-K · filed 2022-03-15 | $20.00K 10-K · filed 2021-03-12 |
| 2020-09-30 | $67.00K 10-Q · filed 2020-11-05 | |
| 2019-12-31 | $213.00K 10-K · filed 2021-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |